‘A compelling story’: Meta-analysis supports omega-3s for heart disease risk reduction

EPA and DHA omega-3s from food and supplements may reduce the risk of coronary heart disease (CHD), according to results of a new meta-analysis.

Data from 18 randomized clinical trials (RCTs) indicated that EPA and DHA were associated with a non-statistically significant 6% risk reduction in CHD among all populations, while the risk reduction increased to a statistically significant 18% when data from 16 prospective cohort studies was assessed.

Continue reading “‘A compelling story’: Meta-analysis supports omega-3s for heart disease risk reduction”

Omega 3 fatty acids help major depression

A trial reported in 2016 indicates that supplementation with omega 3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can help improve major depression.

The study shows that both high levels of EPA+DHA at baseline and supplementation with these two omega 3 fatty acids result in favorable post-treatment outcomes in major depression patients.

Continue reading “Omega 3 fatty acids help major depression”